As the use of glaucoma drainage implants (GDIs) continues to expand in clinical practice, surgeons are becoming more attuned ...

Rahul Tonk, MD, MBA, a cornea, cataract, and refractive surgeon at The Princeton Eye Group and Wills Eye Hospital, presents key insights from his talks at EnVision Summit 2026, a conference he ...

Nicole Bajic, MD, outlines key takeaways from her case study involving Descemet membrane detachment occurring in the setting of focal canaloplasty using the Streamline Surgical System.

Leukemic ocular involvement arises from direct infiltration, hematologic derangements (anemia, thrombocytopenia, ...

Shameema Sikder, MD, details a session she presented with Roomasa Channa, MD, at EnVision Summit 2026.

PDE6A-associated RP, a rare form of inherited retinal disease (IRD), is characterized by nyctalopia, visual field defects, and significant loss of visual acuity (VA). The disease primarily affects the ...

Bonnie An Henderson, MD, founder of EnVision Summit, highlights how the annual conference integrates MD and OD tracks, practical subspecialty updates, and structured opportunities for connection ...

“Chronic noninfectious uveitis treated with systemic IMT is associated with fewer ocular complications and better control of inflammation. The results suggest that systemic IMT may be a more reliable ...

New AAV therapy for retinitis pigmentosa completes Phase I/II dosing, aiming to protect cones and slow vision loss; first ...

An evaluation of commercially available red light devices used to control myopia found that the devices exceeded established safety levels and may damage vision. The recommended duration for red light ...

Stephenson, MD, FACS, shares insights on evolving LAL technology and best practices for managing the ocular surface before ...

China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...